newsfilter
← Latest News
GlobeNewswire·

Vyant Bio to Present at The Benchmark Company Discovery One-on-One Investor Conference

Cherry Hill, N.J.,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. ("Vyant Bio", the "Company") (NASDAQ:VYNT), an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system (